Michael Greger: Friday Favorites: What Is Creatine? Its Sarcopenia Benefits and Potential Side Effects?

🟢
Peer-Reviewed Research
M
Michael Greger

Video Summary · February 6, 2026

View Full Protocol →

Key Takeaways

  • Take 3g creatine monohydrate daily (preferably post-workout) combined with resistance training to combat age-related muscle loss (sarcopenia).
  • Pair creatine with progressive strength training (2-3 sessions/week) for at least 12 weeks to see measurable benefits in muscle mass and strength.
  • Choose high-purity creatine supplements (like Bulk Supplements brand) to avoid contaminants – avoid getting equivalent dose from meat due to carcinogen risks.
  • Inform your doctor if you start creatine supplementation as it may temporarily elevate creatinine levels (a kidney function marker) without actual kidney impairment.

Supplements & Protocols Mentioned

  • Creatine monohydrate: 3g/day (slow saturation) or 20g/day for 1 week (loading phase). Optimal timing: post-workout.
  • Resistance training: 2-3 sessions/week minimum when using creatine for sarcopenia prevention.

Notable Quotes

“Creatine monohydrate is the single most effective ergogenic supplement available to athletes for increasing exercise capacity and lean body mass during training.”

Bottom Line

For fighting age-related muscle loss, combine 3g daily creatine monohydrate with regular strength training, choosing third-party tested supplements for purity.

Explore supplements mentioned in this video

Shop on iHerb →

Explore More

Watch the Full Video

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

From Our Research Network

Part of the Evidence-Based Research Network

Similar Posts